Navigation
banner

Ocular Diseases Drug Discovery

2017-11-212017-12-202017-11-20
EARLY BIRD DISCOUNT! Register by Dec 20, 2017 to receive 20% off your registration!
Or Register 3 for the price of 2 with the coupon code rcdvb!


registration button

Subscribe for updates




Dear Colleague,

The 10th Ocular Diseases Drug Discovery Conference is scheduled for March 20-21, 2018 in San Diego, CA. We are excited to have representatives from the industry and academic sectors to discuss technologies and targets that are continually changing the way ocular diseases are treated. Drug delivery is always improving as we look at for better methods to penetrate anterior and poster segments of the eye. Successes in gene therapy and regenerative medicine are proving to be interesting approaches to discuss in detail pre-clinically and clinically. We are inviting leading scientists, researchers, and experts to discuss and collaborate on combating various ocular diseases.

Session Topics

  1. Opening Keynote Session: Historical Perspective and State of the Industry
  2. Preclinical Development of Novel Technologies
  3. Translational Studies and Lessons Learned
  4. Partnering between Industry, Academia and CROs to Advance Research
  5. Panel on Funding
  6. Panel on Regulatory Challenges
  7. Start-Up Showcase (Lunch Session)
  8. Closing Keynote Session: Predictions for Future

We hope to see you there!

Best regards,
The 2018 Advisory Committee

2018 ADVISORY BOARD MEMBERS
Matthias Birkhoff, Aptar
Oscar Cuzzani, BioTime
Emmett Cunningham, Clarus Ventures
Rafal Farjo, EyeCRO LLC
Rangaramujam Kannan, John Hopkins University